Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,450.00
+40.00 (0.62%)
At close: Apr 29, 2026

Seoulin Bioscience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
731.982,914-117.5510,15915,589
Upgrade
Depreciation & Amortization
1,1631,3651,2871,0171,930
Upgrade
Loss (Gain) From Sale of Assets
065.1131.420.65-14,092
Upgrade
Asset Writedown & Restructuring Costs
373.89152.6-393.031,044
Upgrade
Loss (Gain) From Sale of Investments
421.13-1,9864,966-2,011-160.11
Upgrade
Loss (Gain) on Equity Investments
-7.53-139.95-85.1-84.76-114.5
Upgrade
Provision & Write-off of Bad Debts
86.41328.55-61.68452.7727.35
Upgrade
Other Operating Activities
-172.01424.551,869-4,1635,535
Upgrade
Change in Accounts Receivable
-743.125,504-6,2693,048-1,314
Upgrade
Change in Inventory
1,897-4,345-7,528-3,918-3,025
Upgrade
Change in Accounts Payable
2,599-6,4472,936-2,1634,435
Upgrade
Change in Other Net Operating Assets
-1,590-2,4473,903-7,086-938.58
Upgrade
Operating Cash Flow
4,760-4,611930.57-4,3568,918
Upgrade
Operating Cash Flow Growth
----142.03%
Upgrade
Capital Expenditures
-392.61-48.45-945.51-461.62-933.29
Upgrade
Sale of Property, Plant & Equipment
-0.49123.7559.8620,418
Upgrade
Cash Acquisitions
----35.23-
Upgrade
Divestitures
-0.08---
Upgrade
Sale (Purchase) of Intangibles
-8.21-13.97--245.42-669.69
Upgrade
Sale (Purchase) of Real Estate
-106.66--28.74.97-66.82
Upgrade
Investment in Securities
-16,2786,42928,576-1,904-49,934
Upgrade
Other Investing Activities
-3.4-12.68-204.53-44.07-312.18
Upgrade
Investing Cash Flow
-16,7896,38927,526-2,665-31,499
Upgrade
Short-Term Debt Issued
-3,000550.555.95125.73
Upgrade
Long-Term Debt Issued
18,270-0.13-30,000
Upgrade
Total Debt Issued
18,2703,000550.6355.9530,126
Upgrade
Short-Term Debt Repaid
-3,050-50-40.18-35.27-38.5
Upgrade
Long-Term Debt Repaid
-172.63-8,475-22,083-296.05-229.77
Upgrade
Total Debt Repaid
-3,223-8,525-22,123-331.32-268.27
Upgrade
Net Debt Issued (Repaid)
15,047-5,525-21,573-275.3729,857
Upgrade
Repurchase of Common Stock
-59.56-1,092-142.62-198.94-80.6
Upgrade
Dividends Paid
-843.6-836.16-1,062-798.49-769.16
Upgrade
Other Financing Activities
-500--02,350-0
Upgrade
Financing Cash Flow
13,644-7,453-22,7781,07729,008
Upgrade
Foreign Exchange Rate Adjustments
-111.722.54-75.93-30.247.83
Upgrade
Miscellaneous Cash Flow Adjustments
-00--00
Upgrade
Net Cash Flow
1,503-5,6535,603-5,9746,475
Upgrade
Free Cash Flow
4,367-4,660-14.95-4,8177,984
Upgrade
Free Cash Flow Growth
----143.19%
Upgrade
Free Cash Flow Margin
5.67%-6.18%-0.02%-4.60%9.91%
Upgrade
Free Cash Flow Per Share
328.13-535.72-1.67-432.86887.61
Upgrade
Cash Interest Paid
37.9148.2520.7910.8314.23
Upgrade
Cash Income Tax Paid
64.081,2951,4085,837668.25
Upgrade
Levered Free Cash Flow
9,929-8,710-12,310-12,85327,527
Upgrade
Unlevered Free Cash Flow
10,332-8,504-10,759-11,42427,667
Upgrade
Change in Working Capital
2,163-7,735-6,958-10,119-841.77
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.